Join to view full profile
460 W 12th AveColumbus, OH 43210
Phone+1 614-366-0172
Dr. Li is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a cancer immunologist and medical oncologist with passion in discovering and translating knowledge to improve care of patients with cancer.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1997 - 1999
Montefiore Medical CenterResidency, 1994 - 1997
Henan Medicine UniversityClass of 1984
Certifications & Licensure
OH State Medical License 2019 - 2028
SC State Medical License 2010 - 2019
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected member of ASCI, AAP and AAAS
Publications & Presentations
PubMed
- 2 citationsRAS Pathway Activation and Microenvironmental Adaptation as Hallmarks of Myeloid Sarcoma.Bettina Nadorp, Audrey Lasry, Sanam Loghavi, Ravi Patel, Hager Mansour
Blood Cancer Discovery. 2026-09-03 - Safety and Clinical Outcomes of a First-in-Human Trial of Point-of-Care Manufactured Trispecific CAR T Cells Targeting CD19, CD20, and CD22.Sumithira Vasu, Nathan Denlinger, No-Joon Song, Danielle Elsberry, Qiuhong Zhao
Blood Cancer Discovery. 2026-09-03 - Repression of ferroptotic cell death mediated antitumor immunity by mitochondrial calcium signaling.Jianwen Chen, Bao Zhao, Hong Dong, Zhiwei Liao, Shen Wang
Proceedings of the National Academy of Sciences of the United States of America. 2026-08-25
Press Mentions
The Surprising COVID Vaccine Side Effect No One's Talking AboutNovember 10th, 2025- 10 Must-Read Posts in Immuno-Oncology This WeekOctober 6th, 2025
- ‘Proteotoxic Shock’: Ohio State Researchers Uncover Hidden Mechanism Behind Immunotherapy FailureOctober 5th, 2025
Grant Support
- Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung CancerOHIO STATE UNIVERSITY2024–2029
- Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial MetabolismOHIO STATE UNIVERSITY2021–2026
- Targeting GRP94-TGF-beta Pathway for Cancer ImmunotherapyOHIO STATE UNIVERSITY2021–2026
- Overcoming hypoxic resistance to anti-cancer therapyOHIO STATE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
